Home
About
Services
Partners
Client Portfolio
News
Contact
UBS boss Ermotti fears Europe’s banks ‘too small to survive’
November 13, 2019
Alibaba launches $13.4 billion Hong Kong listing to fund expansion
November 13, 2019
0
Biotech-for-hire PeptiDream charts new path and becomes short target
Published by
Muller&Green
at
November 13, 2019
Categories
RSS
Tags
The promise of PeptiDream Inc’s drug-discovery technology and its lucrative research-for-hire contracts have made it a darling of the Tokyo stock market. Now, those gains have made it a target for short-seller Muddy Waters.
Powered by
WPeMatico
Muller&Green
Related posts
November 10, 2024
How ReelShort CEO Joey Jia Used a Chinese Trend to Disrupt the U.S. Entertainment Industry
Read more
November 5, 2024
Why Sit-Down Chain Restaurants Are Struggling
Read more
November 5, 2024
These Taiwanese Companies Are Turning Waste Into Building Materials
Read more